Psychiatry · Marlton, NJ
NPI
1245357235
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5000 Sagemore Dr Ste 205
Marlton, NJ, 08053
Phone (856) 985-3030
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$151K
941 prescriptions
Company payments, 2025
$533
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Margaret S Harbison prescribed most often to Medicare patients was Escitalopram Oxalate, with 78 prescriptions and refills. In total Margaret S Harbison wrote 941 Medicare prescriptions that cost $151K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Escitalopram Oxalate Generic | 78 | 186 | 20 | $1,003 |
| Bupropion Xl Bupropion Hcl | 59 | 158 | 13 | $1,581 |
| Clonazepam Generic | 59 | 59 | Under 11 | $230 |
| Mirtazapine Generic | 57 | 97 | Under 11 | $1,102 |
| Alprazolam Generic | 51 | 59 | 11 | $334 |
| Fluoxetine Hcl Generic | 48 | 91 | Under 11 | $431 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 37 | 37 | Under 11 | $819 |
| Sertraline Hcl Generic | 34 | 54 | Under 11 | $176 |
| Lorazepam Generic | 29 | 29 | Under 11 | $98.82 |
| Buspirone Hcl Generic | 29 | 63 | Under 11 | $484 |
| Aripiprazole Generic | 29 | 52 | Under 11 | $381 |
| Paroxetine Cr Paroxetine Hcl | 26 | 26 | Under 11 | $892 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 25 | 63 | Under 11 | $1,881 |
| Lamotrigine Generic | 24 | 61 | Under 11 | $410 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 24 | 24 | Under 11 | $828 |
Brand drugs: 133 claims; generic drugs: 808 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret S Harbison $533 ($533 in general payments such as food, travel and fees) from 11 companies. The largest payer was Vanda Pharmaceuticals Inc. with $170.
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. VNDA | 12 | $170 |
| Tris Pharma Inc | 4 | $69.74 |
| Collegium Pharmaceutical, Inc. COLL | 3 | $54.57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $54.36 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $52.76 |
| Abbvie Inc. ABBV | 2 | $35.61 |
| Lundbeck LLC | 2 | $30.85 |
| Axsome Therapeutics, Inc. AXSM | 1 | $18.96 |
| Bausch Health US, LLC BHC | 1 | $17.41 |
| Vertical Pharmaceuticals, LLC | 1 | $14.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.